XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues $ 759 $ 0 $ 2,763 $ 0
Cost of revenues 806 0 2,667 0
Gross (loss) profit (47) 0 96 0
Operating expenses        
Research and development 10,136 9,462 32,503 25,741
Selling, general and administrative 5,184 5,648 17,228 18,502
Exit and termination (benefits) costs (70) (929) 1,007 2,946
Total operating expenses 15,250 14,181 50,738 47,189
Loss from operations (15,297) (14,181) (50,642) (47,189)
Interest income 1,960 2,979 6,637 9,504
Gain on disposal of assets 0 0 0 3
Other income, net 0 0 0 32
Net loss $ (13,337) $ (11,202) $ (44,005) $ (37,650)
Net loss per share, basic (in USD per share) $ (0.08) $ (0.06) $ (0.25) $ (0.21)
Net loss per share, diluted (in USD per share) $ (0.08) $ (0.06) $ (0.25) $ (0.21)
Weighted-average shares outstanding, basic (in shares) 175,652,193 173,612,768 175,106,583 175,302,069
Weighted-average shares outstanding, diluted (in shares) 175,652,193 173,612,768 175,106,583 175,302,069
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Research and development services   Research and development services Research and development services
Government Contract        
Operating expenses        
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]   Research and development services    
Research and development services        
Cost of revenues $ 806 $ 0 $ 2,667 $ 0